Effect of Insurance Coverage on Prescribing Patterns Following Heart Attack

and 0.72 (95% CI, 0.54 to 0.96), respectively. Examination of the use of these agents over time suggests that decreases in the use of calcium channel blockers and increases in the use of β blockers observed between 1986 and 1993 occurred more rapidly for HMO than for FFS patients. Conclusion